Rapid detection and quantitation of BRAF mutations in hairy cell leukemia using a sensitive pyrosequencing assay

American Journal of Clinical Pathology

Volumn 138, Issue 1, 2012, Pages 153-156

  Verma, Shalini ^a   Greaves, Wesley O ^a   Ravandi, Farhad ^a   Reddy, Neelima ^a   Bueso Ramos, Carlos E ^a   O'Brien, Susan ^a   Thomas, Deborah A ^a   Kantarjian, Hagop ^a   Medeiros, L Jeffrey ^a   Luthra, Rajyalakshmi ^a   Patel, Keyur P ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Hairy cell leukemia; Pyrosequencing

Indexed keywords

B RAF KINASE;

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; EXON; FEMALE; GENE MUTATION; HAIRY CELL LEUKEMIA; HUMAN; MALE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PYROSEQUENCING; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS;

ADULT; AGED; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; HUMANS; LEUKEMIA, HAIRY CELL; MALE; MIDDLE AGED; MUTATION; PROTO-ONCOGENE PROTEINS B-RAF;

EID: 84864219291     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPL0OPXI9LZITV     Document Type: Article

References (21)

1. Foucar K, Falini B, Catovsky D, et al. In: Hairy cell leukemia. In: Swerdlow SH, Campos E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008:188-190.
2. Summers TA, Jaffe ES. Hairy cell leukemia diagnostic criteria and differential diagnosis. Leuk Lymphoma. 2011;52(suppl 2):6-10.
3. Pris M, Foucar K, Mollejo M, et al. Splenic B-cell lymphoma/leukaemia, unclassifiable. In: Swerdlow SH, Campos E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2008;191-193.
4. Ravandi F, O'Brien S, Jorgensen J, et al. Phase II study of cladribine followed by rituximab in patients with hairy cell leukemia. Blood. 2011;118:3818-3823.
5. Flinn IW, Kopecky KJ, Foucar MK, et al. Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin. Blood. 2000;96:2981-2986.
6. Chadha P, Rademaker AW, Mendiratta P, et al. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA): long-term follow-up of the Northwestern University experience. Blood. 2005;106:241-246.
7. Else M, Dearden CE, Matutes E, et al. Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis. Br J Haematol. 2009;145:733-740.
8. Tiacci E, Trifonov V, Schiavoni G, et al. BRAF mutations in hairy-cell leukemia. N Engl J Med. 2011;364:2305-2315.
9. Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949-954.
10. Halilovic E, Solit DB. Therapeutic strategies for inhibiting oncogenic BRAF signaling. Curr Opin Pharmacol. 2008;8:419-426.
11. Eggermont A M, Robert C. New drugs in melanoma: it's a whole new world. Eur J Cancer. 2011;47:2150-2157.
12. Chapman PB, Hauschild A, Robert C, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med. 2011;364:2507-2516.
13. Tiacci E, Schiavoni G, Forconi F, et al. Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation. Blood. 2012;119:192-195.
14. Boyd EM, Bench AJ, van 't Veer MB, et al. High resolution melting analysis for detection of BRAF exon 15 mutations in hairy cell leukaemia and other lymphoid malignancies. Br J Haematol. 2011;155:609-612.
15. Ronaghi M, Karamohamed S, Pettersson B, et al. Real-time DNA sequencing using detection of pyrophosphate release. Anal Biochem. 1996;242:84-89. (Pubitemid 26378519)
16. Ronaghi M, Uhlen M, Nyren P. A sequencing method based on real-time pyrophosphate. Science. 1998;281:363-365. (Pubitemid 28340773)
17. Ronaghi M. Pyrosequencing sheds light on DNA sequencing. Genome Res. 2001;11:3-11. (Pubitemid 32117949)
18. Fakhrai-Rad H, Pourmand N, Ronaghi M. Pyrosequencing: an accurate detection platform for single nucleotide polymorphisms. Hum Mutat. 2002;19:479-485. (Pubitemid 34461621)
19. Pourmand N, Elahi E, Davis RW, et al. Multiplex pyrosequencing. Nucleic Acids Res. 2002;30:e31.
20. Kamiguti AS, Harris RJ, Slupsky JR, et al. Regulation of hairy-cell survival through constitutive activation of mitogen-activated protein kinase pathways. Oncogene. 2003;22:2272-2284. (Pubitemid 36566783)
21. Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene. 2007;26:3291-3310. (Pubitemid 46763022)